CIK 0001661053
- Non-accelerated filer
- Smaller reporting company
enVVeno Medical Corp
Sign in to watch- Ticker
- NVNO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330936180
- Phone
- +1 949-261-2900
- Business address
- 70 DOPPLER, IRVINE, CA, 92618
- Former names
- Hancock Jaffe Laboratories, Inc.
- 4 Exercise or conversion Director acquired 1,041 shares (option exercise)
- 4 Exercise or conversion Director acquired 1,041 shares (option exercise)
- 4 Open-market buy Director bought 7,751 shares at $6.14 ($47,591)
- 4 Open-market buy Director bought 1,000 shares at $3.85 ($3,850)
- 4 Open-market buy Chief Executive Officer bought 2,500 shares at $3.80 ($9,500)
- 4 Grant or award Chief Executive Officer acquired 200,000 shares (grant or award)
- 4 Grant or award SVP & Chief Medical Officer acquired 100,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 50,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy CEO bought 2,000 shares at $7.43 ($14,860)
- 4 Exercise or conversion Director acquired 388 shares (option exercise)
- 4 Open-market buy CEO bought 2,000 shares at $7.87 ($15,740)
- 4 Exercise or conversion Director acquired 1,042 shares (option exercise)
- 4 Exercise or conversion Director acquired 1,042 shares (option exercise)
- 4 Open-market buy Director bought 1,300 shares at $7.70 ($10,010)
- 4 Open-market buy Director bought 2,000 shares at $6.25 ($12,500)
- 4 Open-market buy SVP & Chief Medical Officer bought 1,600 shares at $5.90 ($9,440)
Page 3 of 6 · 113 filings